nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCB1—melanoma	0.169	1	CbGaD
Nelfinavir—ABCG2—Vemurafenib—melanoma	0.12	0.187	CbGbCtD
Nelfinavir—ABCG2—Dactinomycin—melanoma	0.0796	0.124	CbGbCtD
Nelfinavir—CYP1A2—Carmustine—melanoma	0.0625	0.0976	CbGbCtD
Nelfinavir—CYP1A2—Vemurafenib—melanoma	0.0494	0.0772	CbGbCtD
Nelfinavir—CYP3A4—Temozolomide—melanoma	0.0472	0.0738	CbGbCtD
Nelfinavir—ABCG2—Docetaxel—melanoma	0.0411	0.0642	CbGbCtD
Nelfinavir—CYP2D6—Vemurafenib—melanoma	0.0407	0.0636	CbGbCtD
Nelfinavir—CYP1A2—Dacarbazine—melanoma	0.0378	0.0592	CbGbCtD
Nelfinavir—CYP3A7—Docetaxel—melanoma	0.0303	0.0474	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0303	0.0474	CbGbCtD
Nelfinavir—ABCB1—Dactinomycin—melanoma	0.0287	0.0449	CbGbCtD
Nelfinavir—CYP3A4—Vemurafenib—melanoma	0.0259	0.0404	CbGbCtD
Nelfinavir—CYP3A5—Docetaxel—melanoma	0.0228	0.0356	CbGbCtD
Nelfinavir—ABCB1—Docetaxel—melanoma	0.0148	0.0232	CbGbCtD
Nelfinavir—CYP3A4—Docetaxel—melanoma	0.00888	0.0139	CbGbCtD
Nelfinavir—Mitiglinide—PPARG—melanoma	0.00148	0.528	CrCbGaD
Nelfinavir—Hyperbilirubinaemia—Docetaxel—melanoma	0.000713	0.00533	CcSEcCtD
Nelfinavir—Myalgia—Vemurafenib—melanoma	0.00071	0.00531	CcSEcCtD
Nelfinavir—Arthralgia—Vemurafenib—melanoma	0.00071	0.00531	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000705	0.00527	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000705	0.00527	CcSEcCtD
Nelfinavir—Affect lability—Temozolomide—melanoma	0.000697	0.00521	CcSEcCtD
Nelfinavir—Liver function test abnormal—Carmustine—melanoma	0.000676	0.00505	CcSEcCtD
Nelfinavir—Mood swings—Temozolomide—melanoma	0.00067	0.00501	CcSEcCtD
Nelfinavir—Inflammation—Docetaxel—melanoma	0.000668	0.005	CcSEcCtD
Nelfinavir—Skin disorder—Vemurafenib—melanoma	0.000661	0.00494	CcSEcCtD
Nelfinavir—Dehydration—Temozolomide—melanoma	0.000658	0.00492	CcSEcCtD
Nelfinavir—Pneumonia—Bleomycin—melanoma	0.00065	0.00486	CcSEcCtD
Nelfinavir—Muscular weakness—Carmustine—melanoma	0.000646	0.00483	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000637	0.00476	CcSEcCtD
Nelfinavir—Neutropenia—Dactinomycin—melanoma	0.000632	0.00473	CcSEcCtD
Nelfinavir—Stomatitis—Bleomycin—melanoma	0.00063	0.00471	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Temozolomide—melanoma	0.000624	0.00467	CcSEcCtD
Nelfinavir—Muscular weakness—Temozolomide—melanoma	0.000624	0.00467	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00062	0.00464	CcSEcCtD
Nelfinavir—Abdominal distension—Temozolomide—melanoma	0.000616	0.0046	CcSEcCtD
Nelfinavir—Pneumonia—Dactinomycin—melanoma	0.000606	0.00453	CcSEcCtD
Nelfinavir—Neutropenia—Carmustine—melanoma	0.000592	0.00442	CcSEcCtD
Nelfinavir—Decreased appetite—Vemurafenib—melanoma	0.000592	0.00442	CcSEcCtD
Nelfinavir—Stomatitis—Dactinomycin—melanoma	0.000588	0.00439	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Vemurafenib—melanoma	0.000588	0.00439	CcSEcCtD
Nelfinavir—Haemoglobin—Bleomycin—melanoma	0.000583	0.00436	CcSEcCtD
Nelfinavir—Haemorrhage—Bleomycin—melanoma	0.00058	0.00434	CcSEcCtD
Nelfinavir—Neutropenia—Temozolomide—melanoma	0.000572	0.00428	CcSEcCtD
Nelfinavir—Hyperglycaemia—Carmustine—melanoma	0.000571	0.00427	CcSEcCtD
Nelfinavir—Pneumonia—Carmustine—melanoma	0.000568	0.00424	CcSEcCtD
Nelfinavir—Hyperglycaemia—Temozolomide—melanoma	0.000552	0.00412	CcSEcCtD
Nelfinavir—Stomatitis—Carmustine—melanoma	0.00055	0.00411	CcSEcCtD
Nelfinavir—Pneumonia—Temozolomide—melanoma	0.000549	0.0041	CcSEcCtD
Nelfinavir—Hepatitis—Dactinomycin—melanoma	0.000541	0.00405	CcSEcCtD
Nelfinavir—Body temperature increased—Vemurafenib—melanoma	0.000538	0.00402	CcSEcCtD
Nelfinavir—Pharyngitis—Dactinomycin—melanoma	0.000537	0.00402	CcSEcCtD
Nelfinavir—Stomatitis—Temozolomide—melanoma	0.000532	0.00397	CcSEcCtD
Nelfinavir—Indinavir—ABCB1—melanoma	0.000521	0.187	CrCbGaD
Nelfinavir—Hepatobiliary disease—Temozolomide—melanoma	0.000516	0.00386	CcSEcCtD
Nelfinavir—Erythema multiforme—Dactinomycin—melanoma	0.000512	0.00383	CcSEcCtD
Nelfinavir—Sinusitis—Temozolomide—melanoma	0.000512	0.00382	CcSEcCtD
Nelfinavir—Haemoglobin—Carmustine—melanoma	0.000509	0.00381	CcSEcCtD
Nelfinavir—Haemorrhage—Carmustine—melanoma	0.000507	0.00379	CcSEcCtD
Nelfinavir—Erythema—Bleomycin—melanoma	0.000505	0.00378	CcSEcCtD
Nelfinavir—Hypersensitivity—Vemurafenib—melanoma	0.000501	0.00375	CcSEcCtD
Nelfinavir—Connective tissue disorder—Carmustine—melanoma	0.000498	0.00372	CcSEcCtD
Nelfinavir—Dermatitis bullous—Docetaxel—melanoma	0.000492	0.00368	CcSEcCtD
Nelfinavir—Haemoglobin—Temozolomide—melanoma	0.000492	0.00368	CcSEcCtD
Nelfinavir—Haemorrhage—Temozolomide—melanoma	0.00049	0.00366	CcSEcCtD
Nelfinavir—Hepatitis—Temozolomide—melanoma	0.00049	0.00366	CcSEcCtD
Nelfinavir—Asthenia—Vemurafenib—melanoma	0.000488	0.00365	CcSEcCtD
Nelfinavir—Pharyngitis—Temozolomide—melanoma	0.000486	0.00363	CcSEcCtD
Nelfinavir—Pruritus—Vemurafenib—melanoma	0.000482	0.0036	CcSEcCtD
Nelfinavir—Connective tissue disorder—Temozolomide—melanoma	0.000481	0.0036	CcSEcCtD
Nelfinavir—Eye disorder—Carmustine—melanoma	0.000473	0.00354	CcSEcCtD
Nelfinavir—Erythema—Dactinomycin—melanoma	0.000471	0.00352	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000471	0.00352	CcSEcCtD
Nelfinavir—Ill-defined disorder—Bleomycin—melanoma	0.000469	0.0035	CcSEcCtD
Nelfinavir—Anaemia—Bleomycin—melanoma	0.000467	0.00349	CcSEcCtD
Nelfinavir—Diarrhoea—Vemurafenib—melanoma	0.000466	0.00348	CcSEcCtD
Nelfinavir—Migraine—Docetaxel—melanoma	0.000463	0.00346	CcSEcCtD
Nelfinavir—Erythema multiforme—Temozolomide—melanoma	0.000463	0.00346	CcSEcCtD
Nelfinavir—Eye disorder—Temozolomide—melanoma	0.000458	0.00342	CcSEcCtD
Nelfinavir—Malaise—Bleomycin—melanoma	0.000456	0.00341	CcSEcCtD
Nelfinavir—Leukopenia—Bleomycin—melanoma	0.000452	0.00338	CcSEcCtD
Nelfinavir—Dizziness—Vemurafenib—melanoma	0.00045	0.00336	CcSEcCtD
Nelfinavir—Angiopathy—Temozolomide—melanoma	0.000444	0.00332	CcSEcCtD
Nelfinavir—Immune system disorder—Temozolomide—melanoma	0.000442	0.00331	CcSEcCtD
Nelfinavir—Malnutrition—Carmustine—melanoma	0.000441	0.0033	CcSEcCtD
Nelfinavir—Erythema—Carmustine—melanoma	0.000441	0.0033	CcSEcCtD
Nelfinavir—Dehydration—Docetaxel—melanoma	0.000438	0.00327	CcSEcCtD
Nelfinavir—Ill-defined disorder—Dactinomycin—melanoma	0.000437	0.00327	CcSEcCtD
Nelfinavir—Anaemia—Dactinomycin—melanoma	0.000436	0.00326	CcSEcCtD
Nelfinavir—Liver function test abnormal—Docetaxel—melanoma	0.000435	0.00325	CcSEcCtD
Nelfinavir—Vomiting—Vemurafenib—melanoma	0.000433	0.00323	CcSEcCtD
Nelfinavir—Myalgia—Bleomycin—melanoma	0.00043	0.00322	CcSEcCtD
Nelfinavir—Abdominal pain upper—Docetaxel—melanoma	0.00043	0.00321	CcSEcCtD
Nelfinavir—Rash—Vemurafenib—melanoma	0.000429	0.00321	CcSEcCtD
Nelfinavir—Dermatitis—Vemurafenib—melanoma	0.000429	0.00321	CcSEcCtD
Nelfinavir—Back pain—Carmustine—melanoma	0.000427	0.00319	CcSEcCtD
Nelfinavir—Headache—Vemurafenib—melanoma	0.000426	0.00319	CcSEcCtD
Nelfinavir—Malnutrition—Temozolomide—melanoma	0.000426	0.00319	CcSEcCtD
Nelfinavir—Erythema—Temozolomide—melanoma	0.000426	0.00319	CcSEcCtD
Nelfinavir—Discomfort—Bleomycin—melanoma	0.000425	0.00318	CcSEcCtD
Nelfinavir—Malaise—Dactinomycin—melanoma	0.000425	0.00318	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000424	0.00317	CcSEcCtD
Nelfinavir—Cramp muscle—Docetaxel—melanoma	0.000424	0.00317	CcSEcCtD
Nelfinavir—Leukopenia—Dactinomycin—melanoma	0.000422	0.00315	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Docetaxel—melanoma	0.000415	0.0031	CcSEcCtD
Nelfinavir—Oedema—Bleomycin—melanoma	0.000412	0.00308	CcSEcCtD
Nelfinavir—Back pain—Temozolomide—melanoma	0.000412	0.00308	CcSEcCtD
Nelfinavir—Saquinavir—ALB—melanoma	0.000408	0.146	CrCbGaD
Nelfinavir—Anaemia—Carmustine—melanoma	0.000408	0.00305	CcSEcCtD
Nelfinavir—Agitation—Carmustine—melanoma	0.000405	0.00303	CcSEcCtD
Nelfinavir—Nausea—Vemurafenib—melanoma	0.000404	0.00302	CcSEcCtD
Nelfinavir—Thrombocytopenia—Bleomycin—melanoma	0.000404	0.00302	CcSEcCtD
Nelfinavir—Myalgia—Dactinomycin—melanoma	0.000401	0.003	CcSEcCtD
Nelfinavir—Bronchospasm—Docetaxel—melanoma	0.0004	0.00299	CcSEcCtD
Nelfinavir—Discomfort—Dactinomycin—melanoma	0.000396	0.00296	CcSEcCtD
Nelfinavir—Ill-defined disorder—Temozolomide—melanoma	0.000395	0.00296	CcSEcCtD
Nelfinavir—Leukopenia—Carmustine—melanoma	0.000395	0.00295	CcSEcCtD
Nelfinavir—Anaemia—Temozolomide—melanoma	0.000394	0.00294	CcSEcCtD
Nelfinavir—Anorexia—Bleomycin—melanoma	0.000393	0.00294	CcSEcCtD
Nelfinavir—Agitation—Temozolomide—melanoma	0.000392	0.00293	CcSEcCtD
Nelfinavir—Saquinavir—ABCB1—melanoma	0.000389	0.139	CrCbGaD
Nelfinavir—Oedema—Dactinomycin—melanoma	0.000385	0.00287	CcSEcCtD
Nelfinavir—Malaise—Temozolomide—melanoma	0.000384	0.00287	CcSEcCtD
Nelfinavir—Convulsion—Carmustine—melanoma	0.000382	0.00286	CcSEcCtD
Nelfinavir—Leukopenia—Temozolomide—melanoma	0.000382	0.00285	CcSEcCtD
Nelfinavir—Neutropenia—Docetaxel—melanoma	0.00038	0.00284	CcSEcCtD
Nelfinavir—Thrombocytopenia—Dactinomycin—melanoma	0.000377	0.00281	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Bleomycin—melanoma	0.000376	0.00281	CcSEcCtD
Nelfinavir—Myalgia—Carmustine—melanoma	0.000375	0.00281	CcSEcCtD
Nelfinavir—Anxiety—Carmustine—melanoma	0.000374	0.0028	CcSEcCtD
Nelfinavir—Paraesthesia—Bleomycin—melanoma	0.00037	0.00277	CcSEcCtD
Nelfinavir—Convulsion—Temozolomide—melanoma	0.000369	0.00276	CcSEcCtD
Nelfinavir—Dyspnoea—Bleomycin—melanoma	0.000368	0.00275	CcSEcCtD
Nelfinavir—Anorexia—Dactinomycin—melanoma	0.000367	0.00274	CcSEcCtD
Nelfinavir—Pneumonia—Docetaxel—melanoma	0.000365	0.00273	CcSEcCtD
Nelfinavir—Arthralgia—Temozolomide—melanoma	0.000363	0.00271	CcSEcCtD
Nelfinavir—Myalgia—Temozolomide—melanoma	0.000363	0.00271	CcSEcCtD
Nelfinavir—Anxiety—Temozolomide—melanoma	0.000362	0.0027	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00036	0.00269	CcSEcCtD
Nelfinavir—Oedema—Carmustine—melanoma	0.00036	0.00269	CcSEcCtD
Nelfinavir—Discomfort—Temozolomide—melanoma	0.000359	0.00268	CcSEcCtD
Nelfinavir—Decreased appetite—Bleomycin—melanoma	0.000358	0.00268	CcSEcCtD
Nelfinavir—Jaundice—Docetaxel—melanoma	0.000354	0.00264	CcSEcCtD
Nelfinavir—Stomatitis—Docetaxel—melanoma	0.000354	0.00264	CcSEcCtD
Nelfinavir—Pain—Bleomycin—melanoma	0.000353	0.00264	CcSEcCtD
Nelfinavir—Thrombocytopenia—Carmustine—melanoma	0.000352	0.00263	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00035	0.00262	CcSEcCtD
Nelfinavir—Oedema—Temozolomide—melanoma	0.000348	0.0026	CcSEcCtD
Nelfinavir—Anorexia—Carmustine—melanoma	0.000343	0.00256	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Docetaxel—melanoma	0.000343	0.00256	CcSEcCtD
Nelfinavir—Epistaxis—Docetaxel—melanoma	0.000342	0.00256	CcSEcCtD
Nelfinavir—Thrombocytopenia—Temozolomide—melanoma	0.000341	0.00255	CcSEcCtD
Nelfinavir—Feeling abnormal—Bleomycin—melanoma	0.00034	0.00254	CcSEcCtD
Nelfinavir—Skin disorder—Temozolomide—melanoma	0.000338	0.00253	CcSEcCtD
Nelfinavir—Hyperhidrosis—Temozolomide—melanoma	0.000336	0.00251	CcSEcCtD
Nelfinavir—Decreased appetite—Dactinomycin—melanoma	0.000334	0.0025	CcSEcCtD
Nelfinavir—Anorexia—Temozolomide—melanoma	0.000332	0.00248	CcSEcCtD
Nelfinavir—Pain—Dactinomycin—melanoma	0.000329	0.00246	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Carmustine—melanoma	0.000328	0.00245	CcSEcCtD
Nelfinavir—Urticaria—Bleomycin—melanoma	0.000328	0.00245	CcSEcCtD
Nelfinavir—Haemoglobin—Docetaxel—melanoma	0.000327	0.00245	CcSEcCtD
Nelfinavir—Rhinitis—Docetaxel—melanoma	0.000326	0.00244	CcSEcCtD
Nelfinavir—Body temperature increased—Bleomycin—melanoma	0.000326	0.00244	CcSEcCtD
Nelfinavir—Haemorrhage—Docetaxel—melanoma	0.000326	0.00243	CcSEcCtD
Nelfinavir—Hepatitis—Docetaxel—melanoma	0.000326	0.00243	CcSEcCtD
Nelfinavir—Insomnia—Carmustine—melanoma	0.000326	0.00243	CcSEcCtD
Nelfinavir—Paraesthesia—Carmustine—melanoma	0.000323	0.00242	CcSEcCtD
Nelfinavir—Pharyngitis—Docetaxel—melanoma	0.000323	0.00242	CcSEcCtD
Nelfinavir—Dyspnoea—Carmustine—melanoma	0.000321	0.0024	CcSEcCtD
Nelfinavir—Somnolence—Carmustine—melanoma	0.00032	0.00239	CcSEcCtD
Nelfinavir—Connective tissue disorder—Docetaxel—melanoma	0.00032	0.00239	CcSEcCtD
Nelfinavir—Feeling abnormal—Dactinomycin—melanoma	0.000317	0.00237	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Temozolomide—melanoma	0.000317	0.00237	CcSEcCtD
Nelfinavir—Insomnia—Temozolomide—melanoma	0.000315	0.00235	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dactinomycin—melanoma	0.000314	0.00235	CcSEcCtD
Nelfinavir—Decreased appetite—Carmustine—melanoma	0.000313	0.00234	CcSEcCtD
Nelfinavir—Paraesthesia—Temozolomide—melanoma	0.000312	0.00233	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Carmustine—melanoma	0.000311	0.00232	CcSEcCtD
Nelfinavir—Dyspnoea—Temozolomide—melanoma	0.00031	0.00232	CcSEcCtD
Nelfinavir—Somnolence—Temozolomide—melanoma	0.000309	0.00231	CcSEcCtD
Nelfinavir—Erythema multiforme—Docetaxel—melanoma	0.000308	0.0023	CcSEcCtD
Nelfinavir—Pain—Carmustine—melanoma	0.000308	0.0023	CcSEcCtD
Nelfinavir—Dyspepsia—Temozolomide—melanoma	0.000306	0.00229	CcSEcCtD
Nelfinavir—Eye disorder—Docetaxel—melanoma	0.000304	0.00227	CcSEcCtD
Nelfinavir—Abdominal pain—Dactinomycin—melanoma	0.000304	0.00227	CcSEcCtD
Nelfinavir—Body temperature increased—Dactinomycin—melanoma	0.000304	0.00227	CcSEcCtD
Nelfinavir—Hypersensitivity—Bleomycin—melanoma	0.000304	0.00227	CcSEcCtD
Nelfinavir—Decreased appetite—Temozolomide—melanoma	0.000302	0.00226	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Temozolomide—melanoma	0.0003	0.00224	CcSEcCtD
Nelfinavir—Pain—Temozolomide—melanoma	0.000297	0.00222	CcSEcCtD
Nelfinavir—Feeling abnormal—Carmustine—melanoma	0.000297	0.00222	CcSEcCtD
Nelfinavir—Asthenia—Bleomycin—melanoma	0.000296	0.00221	CcSEcCtD
Nelfinavir—Angiopathy—Docetaxel—melanoma	0.000295	0.00221	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Carmustine—melanoma	0.000294	0.0022	CcSEcCtD
Nelfinavir—Immune system disorder—Docetaxel—melanoma	0.000294	0.0022	CcSEcCtD
Nelfinavir—Pruritus—Bleomycin—melanoma	0.000292	0.00218	CcSEcCtD
Nelfinavir—Feeling abnormal—Temozolomide—melanoma	0.000287	0.00214	CcSEcCtD
Nelfinavir—Body temperature increased—Carmustine—melanoma	0.000285	0.00213	CcSEcCtD
Nelfinavir—Abdominal pain—Carmustine—melanoma	0.000285	0.00213	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Temozolomide—melanoma	0.000284	0.00213	CcSEcCtD
Nelfinavir—Erythema—Docetaxel—melanoma	0.000283	0.00212	CcSEcCtD
Nelfinavir—Malnutrition—Docetaxel—melanoma	0.000283	0.00212	CcSEcCtD
Nelfinavir—Hypersensitivity—Dactinomycin—melanoma	0.000283	0.00212	CcSEcCtD
Nelfinavir—Urticaria—Temozolomide—melanoma	0.000276	0.00207	CcSEcCtD
Nelfinavir—Asthenia—Dactinomycin—melanoma	0.000276	0.00206	CcSEcCtD
Nelfinavir—Abdominal pain—Temozolomide—melanoma	0.000275	0.00206	CcSEcCtD
Nelfinavir—Body temperature increased—Temozolomide—melanoma	0.000275	0.00206	CcSEcCtD
Nelfinavir—Back pain—Docetaxel—melanoma	0.000274	0.00205	CcSEcCtD
Nelfinavir—Muscle spasms—Docetaxel—melanoma	0.000272	0.00204	CcSEcCtD
Nelfinavir—Hypersensitivity—Carmustine—melanoma	0.000265	0.00198	CcSEcCtD
Nelfinavir—Diarrhoea—Dactinomycin—melanoma	0.000263	0.00197	CcSEcCtD
Nelfinavir—Vomiting—Bleomycin—melanoma	0.000262	0.00196	CcSEcCtD
Nelfinavir—Anaemia—Docetaxel—melanoma	0.000262	0.00196	CcSEcCtD
Nelfinavir—Rash—Bleomycin—melanoma	0.00026	0.00194	CcSEcCtD
Nelfinavir—Dermatitis—Bleomycin—melanoma	0.00026	0.00194	CcSEcCtD
Nelfinavir—Asthenia—Carmustine—melanoma	0.000258	0.00193	CcSEcCtD
Nelfinavir—Hypersensitivity—Temozolomide—melanoma	0.000256	0.00192	CcSEcCtD
Nelfinavir—Leukopenia—Docetaxel—melanoma	0.000254	0.0019	CcSEcCtD
Nelfinavir—Asthenia—Temozolomide—melanoma	0.00025	0.00187	CcSEcCtD
Nelfinavir—Diarrhoea—Carmustine—melanoma	0.000246	0.00184	CcSEcCtD
Nelfinavir—Pruritus—Temozolomide—melanoma	0.000246	0.00184	CcSEcCtD
Nelfinavir—Convulsion—Docetaxel—melanoma	0.000246	0.00184	CcSEcCtD
Nelfinavir—Nausea—Bleomycin—melanoma	0.000245	0.00183	CcSEcCtD
Nelfinavir—Vomiting—Dactinomycin—melanoma	0.000245	0.00183	CcSEcCtD
Nelfinavir—Rash—Dactinomycin—melanoma	0.000242	0.00181	CcSEcCtD
Nelfinavir—Arthralgia—Docetaxel—melanoma	0.000241	0.0018	CcSEcCtD
Nelfinavir—Myalgia—Docetaxel—melanoma	0.000241	0.0018	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00024	0.00179	CcSEcCtD
Nelfinavir—Dizziness—Carmustine—melanoma	0.000238	0.00178	CcSEcCtD
Nelfinavir—Diarrhoea—Temozolomide—melanoma	0.000238	0.00178	CcSEcCtD
Nelfinavir—Oedema—Docetaxel—melanoma	0.000231	0.00173	CcSEcCtD
Nelfinavir—Dizziness—Temozolomide—melanoma	0.00023	0.00172	CcSEcCtD
Nelfinavir—Vomiting—Carmustine—melanoma	0.000229	0.00171	CcSEcCtD
Nelfinavir—Nausea—Dactinomycin—melanoma	0.000228	0.00171	CcSEcCtD
Nelfinavir—Rash—Carmustine—melanoma	0.000227	0.0017	CcSEcCtD
Nelfinavir—Dermatitis—Carmustine—melanoma	0.000227	0.00169	CcSEcCtD
Nelfinavir—Thrombocytopenia—Docetaxel—melanoma	0.000226	0.00169	CcSEcCtD
Nelfinavir—Headache—Carmustine—melanoma	0.000225	0.00169	CcSEcCtD
Nelfinavir—Skin disorder—Docetaxel—melanoma	0.000225	0.00168	CcSEcCtD
Nelfinavir—Vomiting—Temozolomide—melanoma	0.000221	0.00165	CcSEcCtD
Nelfinavir—Anorexia—Docetaxel—melanoma	0.00022	0.00165	CcSEcCtD
Nelfinavir—Rash—Temozolomide—melanoma	0.000219	0.00164	CcSEcCtD
Nelfinavir—Dermatitis—Temozolomide—melanoma	0.000219	0.00164	CcSEcCtD
Nelfinavir—Headache—Temozolomide—melanoma	0.000218	0.00163	CcSEcCtD
Nelfinavir—Nausea—Carmustine—melanoma	0.000214	0.0016	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Docetaxel—melanoma	0.000211	0.00158	CcSEcCtD
Nelfinavir—Insomnia—Docetaxel—melanoma	0.000209	0.00156	CcSEcCtD
Nelfinavir—Paraesthesia—Docetaxel—melanoma	0.000208	0.00155	CcSEcCtD
Nelfinavir—Nausea—Temozolomide—melanoma	0.000207	0.00154	CcSEcCtD
Nelfinavir—Dyspnoea—Docetaxel—melanoma	0.000206	0.00154	CcSEcCtD
Nelfinavir—Somnolence—Docetaxel—melanoma	0.000206	0.00154	CcSEcCtD
Nelfinavir—Dyspepsia—Docetaxel—melanoma	0.000204	0.00152	CcSEcCtD
Nelfinavir—Decreased appetite—Docetaxel—melanoma	0.000201	0.0015	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Docetaxel—melanoma	0.0002	0.00149	CcSEcCtD
Nelfinavir—Pain—Docetaxel—melanoma	0.000198	0.00148	CcSEcCtD
Nelfinavir—Feeling abnormal—Docetaxel—melanoma	0.000191	0.00142	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Docetaxel—melanoma	0.000189	0.00141	CcSEcCtD
Nelfinavir—Body temperature increased—Docetaxel—melanoma	0.000183	0.00137	CcSEcCtD
Nelfinavir—Abdominal pain—Docetaxel—melanoma	0.000183	0.00137	CcSEcCtD
Nelfinavir—Hypersensitivity—Docetaxel—melanoma	0.00017	0.00127	CcSEcCtD
Nelfinavir—Asthenia—Docetaxel—melanoma	0.000166	0.00124	CcSEcCtD
Nelfinavir—Pruritus—Docetaxel—melanoma	0.000164	0.00122	CcSEcCtD
Nelfinavir—Diarrhoea—Docetaxel—melanoma	0.000158	0.00118	CcSEcCtD
Nelfinavir—Dizziness—Docetaxel—melanoma	0.000153	0.00114	CcSEcCtD
Nelfinavir—Vomiting—Docetaxel—melanoma	0.000147	0.0011	CcSEcCtD
Nelfinavir—Rash—Docetaxel—melanoma	0.000146	0.00109	CcSEcCtD
Nelfinavir—Dermatitis—Docetaxel—melanoma	0.000146	0.00109	CcSEcCtD
Nelfinavir—Headache—Docetaxel—melanoma	0.000145	0.00108	CcSEcCtD
Nelfinavir—Nausea—Docetaxel—melanoma	0.000137	0.00103	CcSEcCtD
Nelfinavir—CYP3A5—Metabolism—GNA11—melanoma	9.68e-06	0.000175	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PLA2G6—melanoma	9.61e-06	0.000174	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GPAM—melanoma	9.58e-06	0.000174	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PLA2G6—melanoma	9.53e-06	0.000173	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—SLC5A5—melanoma	9.53e-06	0.000173	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIP4K2A—melanoma	9.47e-06	0.000172	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC6A11—melanoma	9.47e-06	0.000172	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—FASN—melanoma	9.47e-06	0.000172	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.47e-06	0.000172	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—VCAN—melanoma	9.39e-06	0.00017	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.39e-06	0.00017	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—SLC5A5—melanoma	9.32e-06	0.000169	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTAP—melanoma	9.21e-06	0.000167	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CD44—melanoma	9.2e-06	0.000167	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GNAQ—melanoma	9.2e-06	0.000167	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—VCAN—melanoma	9.17e-06	0.000166	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ABCB1—melanoma	9.14e-06	0.000166	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PRKCA—melanoma	9.12e-06	0.000165	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ERCC2—melanoma	9.05e-06	0.000164	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PRKCA—melanoma	9.04e-06	0.000164	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CG—melanoma	9.03e-06	0.000164	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GNAQ—melanoma	9e-06	0.000163	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CD44—melanoma	9e-06	0.000163	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ERCC2—melanoma	8.97e-06	0.000163	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.89e-06	0.000161	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP1B1—melanoma	8.82e-06	0.00016	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PPARG—melanoma	8.71e-06	0.000158	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—VCAN—melanoma	8.64e-06	0.000157	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP1B1—melanoma	8.63e-06	0.000156	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.58e-06	0.000155	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—VCAN—melanoma	8.56e-06	0.000155	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PRKCA—melanoma	8.42e-06	0.000153	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ERCC2—melanoma	8.35e-06	0.000151	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PHGDH—melanoma	8.21e-06	0.000149	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—LUM—melanoma	8.21e-06	0.000149	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PLA2G6—melanoma	8.15e-06	0.000148	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.1e-06	0.000147	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.09e-06	0.000147	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HPSE—melanoma	8.05e-06	0.000146	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CD—melanoma	7.93e-06	0.000144	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	7.93e-06	0.000144	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP17A1—melanoma	7.92e-06	0.000144	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CUBN—melanoma	7.9e-06	0.000143	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ALB—melanoma	7.83e-06	0.000142	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.82e-06	0.000142	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.81e-06	0.000142	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP17A1—melanoma	7.73e-06	0.00014	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CG—melanoma	7.72e-06	0.00014	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	7.71e-06	0.00014	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SDHD—melanoma	7.63e-06	0.000138	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—BSG—melanoma	7.63e-06	0.000138	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CSPG4—melanoma	7.63e-06	0.000138	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GNA11—melanoma	7.48e-06	0.000136	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PPARG—melanoma	7.45e-06	0.000135	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GPAM—melanoma	7.39e-06	0.000134	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—FASN—melanoma	7.32e-06	0.000133	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—VCAN—melanoma	7.32e-06	0.000133	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GNA11—melanoma	7.3e-06	0.000132	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP17A1—melanoma	7.29e-06	0.000132	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ABCB1—melanoma	7.27e-06	0.000132	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP17A1—melanoma	7.22e-06	0.000131	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—SLC5A5—melanoma	7.2e-06	0.000131	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	7.16e-06	0.00013	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—FASN—melanoma	7.15e-06	0.00013	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CG—melanoma	7.15e-06	0.00013	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.12e-06	0.000129	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ABCB1—melanoma	7.1e-06	0.000129	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CG—melanoma	7.08e-06	0.000128	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	7.03e-06	0.000127	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—SLC5A5—melanoma	7.03e-06	0.000127	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GNAQ—melanoma	6.96e-06	0.000126	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CD44—melanoma	6.96e-06	0.000126	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.93e-06	0.000126	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CB—melanoma	6.92e-06	0.000125	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PPARG—melanoma	6.9e-06	0.000125	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GNA11—melanoma	6.88e-06	0.000125	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTGS2—melanoma	6.85e-06	0.000124	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PPARG—melanoma	6.84e-06	0.000124	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GNA11—melanoma	6.82e-06	0.000124	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.81e-06	0.000123	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GNAQ—melanoma	6.79e-06	0.000123	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CD44—melanoma	6.79e-06	0.000123	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CD—melanoma	6.78e-06	0.000123	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.75e-06	0.000122	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—FASN—melanoma	6.73e-06	0.000122	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALB—melanoma	6.7e-06	0.000121	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PRKCA—melanoma	6.69e-06	0.000121	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.68e-06	0.000121	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—FASN—melanoma	6.68e-06	0.000121	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1B1—melanoma	6.67e-06	0.000121	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ERCC2—melanoma	6.63e-06	0.00012	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SLC5A5—melanoma	6.62e-06	0.00012	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CG—melanoma	6.59e-06	0.000119	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SLC5A5—melanoma	6.57e-06	0.000119	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PRKCA—melanoma	6.54e-06	0.000118	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1B1—melanoma	6.51e-06	0.000118	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ERCC2—melanoma	6.48e-06	0.000118	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GNAQ—melanoma	6.4e-06	0.000116	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CD44—melanoma	6.4e-06	0.000116	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPARG—melanoma	6.36e-06	0.000115	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CD44—melanoma	6.34e-06	0.000115	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GNAQ—melanoma	6.34e-06	0.000115	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PLA2G6—melanoma	6.29e-06	0.000114	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CD—melanoma	6.28e-06	0.000114	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CD—melanoma	6.23e-06	0.000113	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.21e-06	0.000113	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—melanoma	6.2e-06	0.000112	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP17A1—melanoma	6.17e-06	0.000112	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.15e-06	0.000112	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—melanoma	6.15e-06	0.000111	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1B1—melanoma	6.13e-06	0.000111	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.09e-06	0.00011	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1B1—melanoma	6.08e-06	0.00011	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.01e-06	0.000109	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—melanoma	5.98e-06	0.000108	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CB—melanoma	5.91e-06	0.000107	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.89e-06	0.000107	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—melanoma	5.86e-06	0.000106	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GNA11—melanoma	5.83e-06	0.000106	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CD—melanoma	5.79e-06	0.000105	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—melanoma	5.72e-06	0.000104	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—FASN—melanoma	5.7e-06	0.000103	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—VCAN—melanoma	5.65e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC5A5—melanoma	5.61e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ABCB1—melanoma	5.49e-06	9.95e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CB—melanoma	5.48e-06	9.92e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CB—melanoma	5.43e-06	9.84e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—melanoma	5.43e-06	9.83e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GNAQ—melanoma	5.42e-06	9.82e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CD44—melanoma	5.42e-06	9.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—melanoma	5.38e-06	9.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.37e-06	9.73e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.31e-06	9.62e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.26e-06	9.53e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CG—melanoma	5.24e-06	9.49e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1B1—melanoma	5.2e-06	9.42e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CG—melanoma	5.12e-06	9.28e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—melanoma	5.11e-06	9.26e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARG—melanoma	5.06e-06	9.16e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PRKCA—melanoma	5.05e-06	9.16e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CB—melanoma	5.05e-06	9.15e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ABCB1—melanoma	5.05e-06	9.15e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ERCC2—melanoma	5.01e-06	9.08e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ABCB1—melanoma	5.01e-06	9.07e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—melanoma	5e-06	9.07e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARG—melanoma	4.94e-06	8.96e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PRKCA—melanoma	4.93e-06	8.94e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ERCC2—melanoma	4.89e-06	8.87e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP17A1—melanoma	4.76e-06	8.63e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—melanoma	4.73e-06	8.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—melanoma	4.69e-06	8.5e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PRKCA—melanoma	4.65e-06	8.42e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ERCC2—melanoma	4.61e-06	8.36e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PRKCA—melanoma	4.61e-06	8.35e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CD—melanoma	4.61e-06	8.35e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.59e-06	8.31e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ERCC2—melanoma	4.57e-06	8.28e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—melanoma	4.55e-06	8.24e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CD—melanoma	4.5e-06	8.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GNA11—melanoma	4.5e-06	8.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—melanoma	4.44e-06	8.05e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—FASN—melanoma	4.4e-06	7.98e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—melanoma	4.36e-06	7.91e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC5A5—melanoma	4.33e-06	7.85e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCB1—melanoma	4.28e-06	7.75e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—melanoma	4.22e-06	7.64e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GNAQ—melanoma	4.18e-06	7.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CD44—melanoma	4.18e-06	7.58e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.15e-06	7.52e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CB—melanoma	4.01e-06	7.27e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1B1—melanoma	4.01e-06	7.27e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—melanoma	3.98e-06	7.21e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CG—melanoma	3.96e-06	7.17e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PRKCA—melanoma	3.94e-06	7.14e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CB—melanoma	3.92e-06	7.11e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ERCC2—melanoma	3.91e-06	7.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—melanoma	3.89e-06	7.05e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CG—melanoma	3.86e-06	7e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARG—melanoma	3.82e-06	6.92e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.79e-06	6.86e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARG—melanoma	3.73e-06	6.76e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CG—melanoma	3.64e-06	6.6e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CG—melanoma	3.61e-06	6.54e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—melanoma	3.61e-06	6.53e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARG—melanoma	3.51e-06	6.37e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARG—melanoma	3.48e-06	6.31e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CD—melanoma	3.48e-06	6.31e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—melanoma	3.47e-06	6.29e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—melanoma	3.44e-06	6.24e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—melanoma	3.44e-06	6.23e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CD—melanoma	3.4e-06	6.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—melanoma	3.39e-06	6.14e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—melanoma	3.35e-06	6.08e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—melanoma	3.34e-06	6.05e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—melanoma	3.31e-06	6e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCB1—melanoma	3.3e-06	5.98e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.24e-06	5.86e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CD—melanoma	3.2e-06	5.8e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CD—melanoma	3.17e-06	5.75e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—melanoma	3.16e-06	5.73e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—melanoma	3.13e-06	5.68e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CG—melanoma	3.08e-06	5.59e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—melanoma	3.08e-06	5.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PRKCA—melanoma	3.04e-06	5.51e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CB—melanoma	3.03e-06	5.5e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ERCC2—melanoma	3.01e-06	5.46e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—melanoma	3.01e-06	5.45e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARG—melanoma	2.98e-06	5.4e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CB—melanoma	2.96e-06	5.37e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—melanoma	2.95e-06	5.34e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—melanoma	2.93e-06	5.32e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CB—melanoma	2.79e-06	5.06e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CB—melanoma	2.77e-06	5.01e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—melanoma	2.76e-06	5.01e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—melanoma	2.74e-06	4.97e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—melanoma	2.73e-06	4.94e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CD—melanoma	2.71e-06	4.91e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—melanoma	2.7e-06	4.9e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—melanoma	2.68e-06	4.85e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—melanoma	2.62e-06	4.75e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—melanoma	2.56e-06	4.64e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—melanoma	2.52e-06	4.56e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—melanoma	2.45e-06	4.43e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—melanoma	2.41e-06	4.37e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—melanoma	2.39e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—melanoma	2.39e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CG—melanoma	2.38e-06	4.31e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CB—melanoma	2.36e-06	4.28e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—melanoma	2.34e-06	4.24e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARG—melanoma	2.3e-06	4.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CD—melanoma	2.09e-06	3.79e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—melanoma	2.07e-06	3.74e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—melanoma	2.04e-06	3.7e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—melanoma	2e-06	3.62e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—melanoma	1.95e-06	3.54e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—melanoma	1.85e-06	3.35e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CB—melanoma	1.82e-06	3.31e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—melanoma	1.81e-06	3.28e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—melanoma	1.8e-06	3.27e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—melanoma	1.7e-06	3.08e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—melanoma	1.69e-06	3.06e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—melanoma	1.58e-06	2.86e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—melanoma	1.51e-06	2.74e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—melanoma	1.47e-06	2.67e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—melanoma	1.44e-06	2.61e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—melanoma	1.39e-06	2.52e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—melanoma	1.38e-06	2.5e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—melanoma	1.18e-06	2.13e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—melanoma	1.11e-06	2.02e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—melanoma	9.08e-07	1.65e-05	CbGpPWpGaD
